Estados Unidos - inglês - NLM (National Library of Medicine)

viiv healthcare company - delavirdine mesylate (unii: 421105krqe) (delavirdine - unii:dol5f9jd3e) - delavirdine mesylate 100 mg - rescriptor tablets are indicated for the treatment of hiv-1 infection in combination with at least 2 other active antiretroviral agents when therapy is warranted. the following should be considered before initiating therapy with rescriptor in treatment-naive patients. there are insufficient data directly comparing antiretroviral regimens containing rescriptor with currently preferred 3-drug regimens for initial treatment of hiv. in studies comparing regimens consisting of 2 nucleoside reverse transcriptase inhibitors (nrtis) (currently considered suboptimal) to rescriptor plus 2 nrtis, the proportion of patients receiving the regimen containing rescriptor who achieved and sustained an hiv-1 rna level <400 copies/ml over 1 year of therapy was relatively low (see description of clinical studies). resistant virus emerges rapidly when rescriptor is administered as monotherapy. therefore, rescriptor should always be administered in combination with other antiretroviral agents. rescriptor tablets are contraindicate

Estados Unidos - inglês - NLM (National Library of Medicine)

avera mckennan hospital - indinavir sulfate (unii: 771h53976q) (indinavir anhydrous - unii:9mg78x43zt) - indinavir anhydrous 400 mg

Estados Unidos - inglês - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - methylergonovine maleate (unii: ir84jpz1rk) (methylergonovine - unii:w53l6fe61v) - following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. for control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder. hypertension; toxemia; pregnancy; and hypersensitivity. methylergonovine maleate has not been associated with drug abuse or dependence of either a physical or psychological nature.

Estados Unidos - inglês - NLM (National Library of Medicine)

atlantic biologicals corp. - methylergonovine maleate (unii: ir84jpz1rk) (methylergonovine - unii:w53l6fe61v) - following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. for control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder. hypertension; toxemia; pregnancy; and hypersensitivity. methylergonovine maleate has not been associated with drug abuse or dependence of either a physical or psychological nature.